Grant: Engage Grants Program
McGill University
$25,000.00
Microfluidic capillary system for rapid differential diagnosis of sepsis
FY 2015-16
Summary
Sepsis is a severe stage of body infection that can lead to organ failure and death. According to World Health
Organization, 20-30 million people are affected by sepsis worldwide-with a mortality rate of 35%. Rapid
diagnosis of sepsis is crucial as each hour of delay in initiation of treatment is associated with an approximate
mean decrease in survival of 7%. Currently, culturing the patient samples, PCR and ELISA techniques are used
to diagnose the septic conditions. However, these methods are time consuming (takes >5 hrs), expensive, and
require qualified technicians to perform the test. Procalcitonin is a specific protein biomarker for sepsis and
microbial infections, which can be measured in patient's blood sample. This proposal describes the
development of a new diagnostic device that allows rapid, highly sensitive, and low-cost measurement of
procalcitonin concentration in blood in less than 15 minutes. this approach relies on the use of a novel
self-powered and self-contained microfluidic capillary circuit to perform a one-step immunoassay. Detection
will be carried out using Europium labelled detection antibody. A large Stokes' shift provided by the time
resolved fluorometry allows more sensitive measurement of the fluorescence. Protocols for immobilization and
preservation of antibodies on the liquid handling microchip will also be developed. Optimization and
calibration of this platform will be carried out using plasma samples spiked with procalcitonin antigen. This
effort allows the introduce an inexpensive procalcitonin point of care test using only finger prick of whole
blood without sacrificing the sensitivity of the assay.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
477887-2015
Name nom
Tabrizian, Maryam
Department département
Biomedical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Microfluidic capillary system for rapid differential diagnosis of sepsis
Keyword
NSERC
Application summary
Sepsis is a severe stage of body infection that can lead to organ failure and death. According to World Health
Organization, 20-30 million people are affected by sepsis worldwide-with a mortality rate of 35%. Rapid
diagnosis of sepsis is crucial as each hour of delay in initiation of treatment is associated with an approximate
mean decrease in survival of 7%. Currently, culturing the patient samples, PCR and ELISA techniques are used
to diagnose the septic conditions. However, these methods are time consuming (takes >5 hrs), expensive, and
require qualified technicians to perform the test. Procalcitonin is a specific protein biomarker for sepsis and
microbial infections, which can be measured in patient's blood sample. This proposal describes the
development of a new diagnostic device that allows rapid, highly sensitive, and low-cost measurement of
procalcitonin concentration in blood in less than 15 minutes. this approach relies on the use of a novel
self-powered and self-contained microfluidic capillary circuit to perform a one-step immunoassay. Detection
will be carried out using Europium labelled detection antibody. A large Stokes' shift provided by the time
resolved fluorometry allows more sensitive measurement of the fluorescence. Protocols for immobilization and
preservation of antibodies on the liquid handling microchip will also be developed. Optimization and
calibration of this platform will be carried out using plasma samples spiked with procalcitonin antigen. This
effort allows the introduce an inexpensive procalcitonin point of care test using only finger prick of whole
blood without sacrificing the sensitivity of the assay.